Avantor, Inc.
AVTRAvantor, Inc. (AVTR) is a global supplier of advanced materials, products, and services to the life sciences, healthcare, and advanced technology industries. The company provides a wide range of specialized consumables, equipment, and custom solutions used in laboratory research, development, and manufacturing processes. Avantor's offerings support scientific innovation and commercialization across various sectors, including pharmaceuticals, biotechnology, and industrial applications.
Company News
Despite Avantor's stock declining 46% over the past year, Chicago-based Kinney Asset Management increased its position to 1.85 million shares worth $23.03 million, making it the fund's largest holding. The move signals confidence in the company's turnaround potential, as management authorizes a $500 million share repurchase program while the comp...
Avantor, Inc. faces a class action lawsuit alleging that company executives failed to disclose weakening competitive positioning and increased competitive intensity affecting its Laboratory Solutions business. The company cut guidance multiple times in 2025 after reporting weak organic sales growth. Stock prices fell significantly following each ...
Levi & Korsinsky, LLP has filed class action securities lawsuits against Avantor, Inc. (AVTR), Coupang, Inc. (CPNG), and DeFi Technologies (DEFT) alleging securities fraud. Avantor investors claim the company made false statements about its competitive positioning and concealed negative effects from increased competition during March 5, 2024 to O...
The Schall Law Firm is seeking investors who purchased Avantor, Inc. securities between March 5, 2024, and October 28, 2025, for a class action lawsuit alleging securities fraud. The firm claims Avantor made false and misleading statements about its competitive position and struggled with increased competition, causing investor losses when the tr...
Law firm alerts shareholders about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations during specific time periods.
